RALA Antibody, FITC conjugated

說明書

中文名稱：

RALA兔多克隆抗體, FITC偶聯
貨號：

CSB-PA019296LC01HU
規格：

￥880
其他：

產品詳情
產品評價
相關產品
靶點詳情

產品詳情

產品名稱：

Rabbit anti-Homo sapiens (Human) RALA Polyclonal antibody
Uniprot No.：

P11233
基因名：

RALA
別名：

MGC48949 antibody; Ral a antibody; Ral A protein antibody; RAL antibody; RALA antibody; RALA_HUMAN antibody; Ras family small GTP binding protein RALA antibody; RAS like protein A antibody; Ras related protein RalA antibody; Ras-related protein Ral-A antibody; v ral simian leukemia viral oncogene homolog A (ras related) antibody; v ral simian leukemia viral oncogene homolog A antibody
宿主：

Rabbit
反應種屬：

Human
免疫原：

Recombinant Human Ras-related protein Ral-A protein (1-203AA)
免疫原種屬：

Homo sapiens (Human)
標記方式：

FITC
克隆類型：

Polyclonal
抗體亞型：

IgG
純化方式：

>95%, Protein G purified
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
產品提供形式：

Liquid
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

功能：

Multifunctional GTPase involved in a variety of cellular processes including gene expression, cell migration, cell proliferation, oncogenic transformation and membrane trafficking. Accomplishes its multiple functions by interacting with distinct downstream effectors. Acts as a GTP sensor for GTP-dependent exocytosis of dense core vesicles. The RALA-exocyst complex regulates integrin-dependent membrane raft exocytosis and growth signaling. Key regulator of LPAR1 signaling and competes with GRK2 for binding to LPAR1 thus affecting the signaling properties of the receptor. Required for anchorage-independent proliferation of transformed cells. During mitosis, supports the stabilization and elongation of the intracellular bridge between dividing cells. Cooperates with EXOC2 to recruit other components of the exocyst to the early midbody. During mitosis, also controls mitochondrial fission by recruiting to the mitochondrion RALBP1, which mediates the phosphorylation and activation of DNM1L by the mitotic kinase cyclin B-CDK1.
基因功能參考文獻：
1. In fact the overexpression of RalGPS2 or of its PH-domain increased markedly the number and the length of nanotubes, while the knock-down of RalGPS2 caused a strong reduction of these structures. Moreover, using a series of RalA mutants impaired in the interaction with different downstream components (Sec5, Exo84, RalBP1) we demonstrated that the interaction of RalA with Sec5 is required for TNTs formation PMID: 29208460
2. Study explored the function of RalA in regulating the localization of AQP3 in androgenindependent prostate cancer and demonstrated that depletion of RalA led to the redistribution of AQP3 into the plasma membrane. PMID: 29532894
3. Data show that ras related GTP binding protein A (Ral A) is necessary for 1-O-Hexadecyl-2-O-methyl-rac-glycerol (HMG)-mediated M phase arrest and induction of apoptosis in Nf1-deficient cells. PMID: 27741517
4. High RalA expression is associated with chronic myelogenous leukemia. PMID: 26967392
5. This study demonstrated that RalA is overactivated in medulloblastoma. PMID: 27566179
6. Study shows the additional benefits of anti-RalA autoantibody as a potential serological biomarker for prostate cancer (PCa), particularly in patients with normal PSA, and further demonstrate the utility of biomarker combinations in the immunodiagnosis of PCa. PMID: 27286458
7. This study identifies a novel regulatory crosstalk between Ral and Arf6 that controls Ral function in cells. PMID: 27269287
8. Lowering the level of cellular FLNA caused an elevation in RalA activity and resulted in selective interference with the normal intracellular trafficking and signaling of the D2R and D3R, through GRK2 and beta-arrestins, respectively. Active RalA was found to interact with GRK2 to sequester it from D2R. Knockdown of FLNA or coexpression of active RalA prevented D3R from coupling with G protein. PMID: 27188791
9. results suggest that the small GTPase RalA plays an important role in promoting invagination and trafficking of caveolae, not by potentiating the association between Cav-1 and FilA but by stimulating PLD2-mediated generation of phosphatidic acid. PMID: 27510034
10. agonist-induced Gbetagamma-mediated conversion of RalA from the GTP-bound form to the GDP-bound form could be a mechanism to facilitate agonist-induced internalization of GPCRs. PMID: 26477566
11. RCC2 exhibits guanine exchange factor activity, in vitro and in cells, for the small GTPase RalA. RCC2 and RalA apparently work together to contribute to the regulation of kinetochore-microtubule interactions in early mitosis. PMID: 26158537
12. striking isoform-specific consequences of distinct CAAX-signaled posttranslational modifications that contribute to the divergent subcellular localization and activity of RalA and RalB. PMID: 26216878
13. expression of K-Ras and RalB and possibly RalA proteins is critical for maintaining low levels of p53, and down-regulation of these GTPases reactivates p53 by significantly enhancing its stability, contributing to suppression of malignant transformation PMID: 25210032
14. These results indicate that MLN8237 treatment may be effective for a subset of patients with PDAC independent of RalA S194 phosphorylation PMID: 24222664
15. microRNA-140 targets RALA and regulates chondrogenic differentiation of human mesenchymal stem cells by translational enhancement of SOX9 and ACAN. PMID: 24063364
16. RalA and RalB exhibit both distinct and redundant roles in tumorigenesis (Review). PMID: 23830877
17. The study found upregulated RalA and RalB activation in colorectal cancer tumor cell lines and tumors. PMID: 22790202
18. We identified interactions between RalA and its effectors sec5 and exo84 in the Exocyst complex as directly necessary for migration and invasion of prostate cancer tumor cells. PMID: 22761837
19. the existence of an ubiquitination/de-ubiquitination cycle superimposed on the GDP/GTP cycle of RalA, involved in the regulation of RalA activity as well as in membrane raft trafficking. PMID: 22700969
20. RalA and RalB differentially regulate development of epithelial tight junctions. PMID: 22013078
21. This study detected RALA level in Chronic myelogenous leukemia cells, which is highly expressed and distributed mainly in the cytoplasm and/or partially in endomembrane. PMID: 22330069
22. RalA is directly regulated by miR-181a and plays an important role in CML. PMID: 22442671
23. Data show that disrupting either RALA or RALBP1 leads to a loss of mitochondrial fission at mitosis, improper segregation of mitochondria during cytokinesis and a decrease in ATP levels and cell number. PMID: 21822277
24. Our results identify a role for RalA and RalB in cell-mediated cytotoxicity PMID: 21810610
25. conclude that the ability of hRgr to activate both Ral and Ras is responsible for its transformation-inducing phenotype and it could be an important contributor in the development of some T-cell malignancies PMID: 21441953
26. The RalA was not only cytoprotective against multiple chemotherapeutic drugs, but also promigratory inducing stress fiber formation, which was accompanied by the activation of Akt and Erk pathways. PMID: 21645515
27. RalA, the binding partner of PKC eta, is involved in not only the keratinocyte differentiation induced by PKCeta overexpression but also in normal keratinocyte differentiation induced by calcium and cholesterol sulfate. PMID: 21346190
28. Correlation between RalA protein expression decrease and absence of regional metastases was revealed for squamous cell lung cancer. PMID: 21634118
29. Ral is a critical regulator in PMN that specifically controls secondary granule release during PMN response to chemoattractant stimulation. PMID: 21282111
30. studies suggest that the expression of RalBP1 is necessary for human cancer cell metastasis; show that the requirement for RalA expression for manifestation of this phenotype is not entirely dependent on a RalA-RalBP1 interaction PMID: 21170262
31. RalA interaction with the Exo84 but not Sec5 exocyst component was necessary for supporting anchorage-independent growth, whereas RalB interaction with Sec5 but not Exo84 was necessary for inhibition of anchorage-independent growth PMID: 21199803
32. RalA is activated by Salmonella infection in a SopE-dependent manner, and is required for exocyst assembly. PMID: 20579884
33. Expression of the small GTPase RalA is required for angiotensin II type I receptor-stimulated inositol phosphate formation. PMID: 20018811
34. Data show that conversion of Ras-expressing keratinocytes from a premalignant to malignant state induced by decreasing E-cadherin function was associated with and required an approximately two to threefold decrease in RalA expression. PMID: 19802010
35. Aurora-A may converge upon oncogenic Ras signaling through RalA. PMID: 19901077
36. differential binding of calmodulin by RalA and RalB PMID: 12034722
37. RALA and RALB collaborate to maintain tumorigenicity through regulation of both proliferation and survival; RALA is dispensable for survival, but is required for anchorage-independent proliferation PMID: 12856001
38. Protein kinase A-dependent activation of Ral regulates cAMP-mediated exocytosis of Weibel-Palade bodies in endothelial cells. PMID: 15130921
39. crystal structure of Clostridium botulinum C3bot1 in complex with RalA (a GTPase of the Ras subfamily) and GDP at a resolution of 2.66 A PMID: 15809419
40. the Ral-CaM complex defines a multifaceted regulatory mechanism for PLC-delta1 activation PMID: 15817490
41. Activation of RalA signaling appears to be a critical step in Ras-induced transformation and tumorigenesis of human cells. PMID: 15950903
42. androgen deprivation of human prostate carcinoma cells activates the small GTPase, RalA, a molecule important for human oncogenesis PMID: 16964283
43. study concludes RalA function is critical to tumor initiation, while RalB is more important for tumor metastasis in the tested pancreatic carcinoma cell lines & argues for critical roles of Ral proteins during progression of Ras-driven pancreatic cancers PMID: 17174914
44. Ral is activated upon BCR stimulation and mediates BCR-controlled activation of AP-1 and NFAT transcription factors. PMID: 17237388
45. analysis of activation and differential expression of RalA and RalB in human bladder cancer PMID: 17606711
46. These data extend understanding of the functional roles of the Ral pathway and begin to identify signaling pathways relevant for organ-specific metastasis. PMID: 17709381
47. Data suggest that RalA and RalB are important, functionally distinct targets for GGTI-mediated tumor apoptosis and growth inhibition. PMID: 17875936
48. RalA and RalB support mitotic progression through mobilization of the exocyst for two spatially and kinetically distinct steps of cytokinesis PMID: 18756269
49. RalGDS and RalA act downstream of Rheb and RalA activation is a crucial step in nutrient-induced mTORC1 activation PMID: 18948269
50. These results establish RalA and GRK2 as key regulators of LPA receptor signalling and demonstrate for the first time that LPA(1) activity facilitates the formation of a novel protein complex between these two proteins. PMID: 19306925
顯示更多

收起更多
亞細胞定位：

Cell membrane; Lipid-anchor; Cytoplasmic side. Cleavage furrow. Midbody, Midbody ring. Mitochondrion.
蛋白家族：

Small GTPase superfamily, Ras family
數據庫鏈接：

HGNC: 9839

OMIM: 179550

KEGG: hsa:5898

STRING: 9606.ENSP00000005257

UniGene: Hs.6906

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WDR5 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
VIM Recombinant Monoclonal Antibody

Applications: ELISA, IHC, IF

Species Reactivity: Human
VDR Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human